Laboratory Testing for Annual Physical in a 56-Year-Old Female
For a healthy 56-year-old woman, focus laboratory testing on diabetes screening (fasting glucose or HbA1c every 3 years if no risk factors, annually if risk factors present) and lipid screening (annually or every 6-12 months), while prioritizing cancer screening procedures over routine laboratory panels.
Diabetes and Metabolic Screening
Diabetes screening should begin at age 35 and be repeated at minimum 3-year intervals if normal, with more frequent testing based on risk factors 1. For your 56-year-old patient:
- Test with fasting plasma glucose, HbA1c, or 2-hour oral glucose tolerance test 1, 2
- Screen annually if she has any risk factors including: overweight/obesity (BMI ≥25 kg/m²), first-degree relative with diabetes, hypertension, HDL <35 mg/dL or triglycerides >250 mg/dL, physical inactivity, history of cardiovascular disease, or high-risk ethnicity 1, 3, 2
- If she has prediabetes (HbA1c 5.7-6.4%), screen yearly 1, 2
Lipid screening should be performed, though specific frequency guidelines for routine screening in this age group are not explicitly detailed in cancer screening guidelines 4. However, for patients on certain medications or with cardiovascular risk factors, testing every 6-12 months is reasonable 4.
Cancer Screening (Not Laboratory Tests)
The most important "screening" for this age group involves procedures rather than laboratory tests:
Breast Cancer Screening
- Annual mammography is recommended 5, 6
- Clinical breast examination annually (preferably before mammography) 7, 5, 7
Cervical Cancer Screening
- Every 5 years with HPV + Pap test (preferred) or every 3 years with Pap test alone 5, 6
- Continue until age 65 if adequate prior screening 5, 6
Colorectal Cancer Screening
- Should have begun at age 45-50 with options including: annual fecal immunochemical test (FIT), colonoscopy every 10 years, or flexible sigmoidoscopy every 5 years 7, 5, 6
What NOT to Routinely Order
Avoid comprehensive laboratory panels without specific indications. Research demonstrates that routine tests like complete blood count, comprehensive metabolic panel, and urinalysis have very low therapeutic yield (0-2.2%) in asymptomatic patients 8. Despite 44-48% of physicians ordering these tests, evidence does not support their routine use 9.
Additional Considerations
- Blood pressure measurement annually 4
- Thyroid testing is NOT routinely recommended unless symptomatic 4
- Hepatitis C screening once if born 1945-1965 or has risk factors 10
- HIV screening should be offered based on risk factors 10
Common Pitfalls to Avoid
Do not order "routine" comprehensive metabolic panels, complete blood counts, or urinalysis in truly asymptomatic patients—these have minimal evidence-based benefit and can lead to false positives and unnecessary follow-up 9, 8. The review of systems and physical examination have higher therapeutic yield (5-7%) than most routine laboratory tests 8.
Focus resources on evidence-based preventive services (mammography, cervical cancer screening, colorectal cancer screening, diabetes screening) rather than comprehensive laboratory testing 10, 11.